Scarica l'app Stockscreener
4.26
27.05%
-1.58
Pre-mercato:
4.41
0.15
+3.52%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché JAGX Giù?
Forum
Previsione
Frazionamento azionario
Jaguar Health Inc Borsa (JAGX) Ultime notizie
Jaguar Health Announces $1.5M Direct Stock Offering - TipRanks
Jaguar Health $1.5M Stock Offering Sparks Retail Buzz; Traders Call It A ‘Dip Opportunity’ By Stocktwits - Investing.com India
Jaguar Health announces $1.5 million direct offering By Investing.com - Investing.com South Africa
Jaguar Health prices 0.25M shares at $6.09 in registered direct offering - MSN
Jaguar Health (JAGX) Announces Direct Offering and Private Placement | JAGX Stock News - GuruFocus
Jaguar Health Prices Offering of Shares, Warrants - marketscreener.com
Jaguar Health announces $1.5 million direct offering - Investing.com
Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | JAGX Stock News - GuruFocus
Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Jaguar Health Secures Fresh Capital: $1.5M Direct Offering Plus WarrantsKey Terms Revealed - Stock Titan
SEC Form 424B5 filed by Jaguar Health Inc. - Quantisnow
Jaguar Health (JAGX) Advances Crofelemer Trial for Rare Pediatri - GuruFocus
First Patient Randomized in Jaguar Health's Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID) | JAGX Sto - GuruFocus
First Patient Randomized in Jaguar Health's Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID) - Yahoo Finance
JAGX: Jaguar Health Coverage Initiated with Buy Rating | JAGX Stock News - GuruFocus
Jaguar Health outlines rare disease catalyst convergence and expedited regulatory pathways for crofelemer following proof-of-concept results - MSN
Jaguar Health, Inc. (NASDAQ:JAGX) Q1 2025 Earnings Call Transcript - MSN
Jaguar Animal Health: Mixed Sentiments in Latest Earnings Call - TipRanks
Jaguar Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Jaguar Health Inc (JAGX) Q1 2025 Earnings Call Highlights: Navigating Challenges with Promising ... - Yahoo Finance
Jaguar Health Reports Q1 2025 Financial Results - TipRanks
Transcript : Jaguar Health, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
Earnings call transcript: Jaguar Health reports Q1 2025 with stock drop - Investing.com India
Jaguar Animal Health Executes Stock Exchange Agreements - TipRanks
Jaguar Health Reports First Quarter 2025 Financials | JAGX Stock News - GuruFocus
JAGX Reports Decrease in Q1 2025 Product Revenue | JAGX Stock News - GuruFocus
Jaguar Health Reports First Quarter 2025 Financials - ACCESS Newswire
JAGXJaguar Health Inc Latest Stock News & Market Updates - Stock Titan
Jaguar Health, Inc. SEC 10-Q Report - TradingView
Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 - GuruFocus
Jaguar Health Earnings Tomorrow: Q1 2025 Results Plus Major Corporate Updates Coming - Stock Titan
Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates - Sacramento Bee
Jaguar Health Strengthens Company's Balance Sheet by Reducing Approximately $10.5 Million of Debt Incurred to Effect 2017 Merger to Approximately $5.7 Million - ACCESS Newswire
Jaguar Health Investor Webcast Rescheduled for Wednesday, November 17th at 8:30 AM Eastern Time - ACCESS Newswire
Jaguar Health (JAGX) to Release Quarterly Earnings on Tuesday - Defense World
Jaguar Health Celebrates National Pet Cancer Awareness Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs - The Globe and Mail
Jaguar Health Highlights Promising Crofelemer Study Results - TipRanks
Jaguar Health to Host Investor Webcast Monday, March 14th at 8:30 AM Eastern Time Regarding Q4 2021 Financials & Corporate Updates - ACCESS Newswire
Jaguar Health Celebrates National Pet Cancer Awareness Month: With its Supportive Cancer Care Drugs, - PharmiWeb.com
Jaguar Health Celebrates National Pet Cancer Awareness Month: Wi - GuruFocus
Jaguar Health Celebrates National Pet Cancer Awareness Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs | JAGX Stock News - GuruFocus
Jaguar Health (JAGX) Advances Crofelemer for Rare Diseases and Breast Cancer | JAGX Stock News - GuruFocus
Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts | JAGX Stock News - GuruFocus
Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts - Yahoo Finance
Article About Jaguar Health Published in Fall 2019 Issue of MicroCap Review Magazine - ACCESS Newswire
Form S-8Securities to be offered to employees in employee benefit plans - ADVFN
Geode Capital Management LLC Has $98,000 Position in Jaguar Health, Inc. (NASDAQ:JAGX) - Defense World
Jaguar Health Announces Closing of $6.0 Million Issuance and Sale of Designation-backed Note Related to Possible Tropical Disease Priority Review Voucher - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Jaguar Health (JAGX) Reports Positive Trial Results for Crofelemer Formulation | JAGX Stock News - GuruFocus
1.52%
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):